I have gone along with the popular belief that a positive FDA decision for Dendreon will result in a share price rerating for Prima.
However, will this in fact be the case?
Perhaps the only thing that will cause a re-rating of the PRR share price will be more boxes being ticked on the way to commercialisation.
E.g.,
Orphan status decision/s.
Trials progress reports.
Takeover interest.
Nasdaq listing.
I am preparing myself for the possibility that the Dendreon FDA decision will not have any impact on PRR -either way. If it was going to, it should have done so already. Afterall, the speculation of a positive decision for Dendreon has been going on and on for several months and has been reflected in an increasing share price. Not so with Prima.
- Forums
- ASX - By Stock
- IMM
- high expectations on dendreon fda decision
high expectations on dendreon fda decision
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
30.0¢ | 30.5¢ | 28.5¢ | $715.2K | 2.430M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 305228 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 36744 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 305228 | 0.290 |
24 | 544409 | 0.285 |
11 | 216592 | 0.280 |
4 | 113663 | 0.275 |
15 | 305814 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 36744 | 2 |
0.300 | 220559 | 13 |
0.305 | 178280 | 11 |
0.310 | 273999 | 6 |
0.315 | 110917 | 5 |
Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |